Longitudinal Outcomes in Pi*MZ Alpha-1 Antitrypsin Deficient Individuals with Tobacco Smoking History from the SPIROMICS Cohort

By sjmartinez • March 13, 2025

Barjaktarevic I, Hixson R, Zhuang Z, Buhr RG, Tejwani V, Barr RG, Bateman LA, Bhatt SP, Bleecker ER, Cooper CB, Curtis JL, Drummond MB, Fortis S, Ghosh AJ, Han M, Hansel NN, Hoffman EA, Ohar J, Martinez FJ, Meyers DA, Paine R 3rd, Pirozzi CS, Sandhaus R, Strange C, Tashkin DP, Wells JM, Woodruff P, Ortega VE. Longitudinal Outcomes in Pi*MZ Alpha-1 Antitrypsin Deficient Individuals with Tobacco Smoking History from the SPIROMICS Cohort. Ann Am Thorac Soc. 2025 Mar 11. doi: 10.1513/AnnalsATS.202411-1209OC. Epub ahead of print. PMID: 40068143.

Tags: Publications, Pulmonary, Critical Care & Sleep Medicine

Effect of Glucagon-Like Peptide 1 Receptor Agonists on Patients With Rheumatoid Arthritis

Kellner DA, Dente E, Tran V, Welsh T, Tran V, Saha A, Baker JF, Elashoff DA, Ranganath VK. Effect of Glucagon-Like Peptide 1 Receptor Agonists[...]

Demographics and Trends of Sudden Cardiac Death-Related Mortality in the United States, 1999 to 2022

Jaiswal V, Kumar D, Mashkoor Y, Latif F, Kanagala SG, Halder A, Jaiswal A, Bandyopadhyay D, Hajra A, Joshi A, Aronow WS, Fonarow GC. Demographics[...]

Machine Learning to Diagnose Complications of Diabetes

Scheideman AF, Shao MM, Zelada H, Cuadros J, Foreman J, Sarder P, Ho C, Ejskjaer N, Fleischer J, Cichosz SL, Armstrong DG, Mathioudakis N, Wang[...]